Anti-cancer effect of engineered recombinant interleukin 18.
Saetang J, Chonpathompikunlert P, Sretrirutchai S, Roongsawang N, Kayasut K, Voravuthikunchai SP, Sukketsiri W, Tipmanee V, Sangkhathat S.
Saetang J, et al. Among authors: tipmanee v.
Adv Clin Exp Med. 2020 Oct;29(10):1135-1143. doi: 10.17219/acem/126298.
Adv Clin Exp Med. 2020.
PMID: 33031647
Free article.